Fresenius Medical Care AG (ETR:FME – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of €35.94 ($38.23) and traded as high as €36.80 ($39.15). Fresenius Medical Care shares last traded at €36.62 ($38.96), with a volume of 803,997 shares trading hands.
Fresenius Medical Care Price Performance
The company has a quick ratio of 0.80, a current ratio of 1.42 and a debt-to-equity ratio of 81.28. The firm’s 50-day moving average is €36.08 and its 200-day moving average is €35.94. The company has a market cap of $11.44 billion, a PE ratio of 22.93, a PEG ratio of 0.40 and a beta of 0.94.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Further Reading
- Five stocks we like better than Fresenius Medical Care
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- How to Start Investing in Real Estate
- Merger or Not, Albertson’s Companies is a Good Buy
- What is a Secondary Public Offering? What Investors Need to Know
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
